Analyzing Bioactive Effects of the Minor Hop Compound Xanthohumol C on Human Breast Cancer Cells Using Quantitative Proteomics

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Mar 16

PMID 30875365

Citations 12

Authors

Simon Roehrer

Verena Stork

Christina Ludwig

Mirjana Minceva

Jurgen Behr

Affiliations

Soon will be listed here.

Abstract

Minor prenylated hop compounds have been attracting increasing attention due to their promising anticarcinogenic properties. Even after intensive purification from natural raw extracts, allocating certain activities to single compounds or complex interactions of the main compound with remaining impurities in very low concentration is difficult. In this study, dose-dependent antiproliferative and cytotoxic effects of the promising xanthohumol (XN) analogue xanthohumol C (XNC) were evaluated and compared to XN and a XN-enriched hop extract (XF). It was demonstrated that the cell growth inhibition of human breast cancer cell line (MCF-7) significantly increases after being treated with XNC compared to XN and XF. Based on label-free data-dependent acquisition proteomics, physiological influences on the proteome of MCF-7 cells were analyzed. Different modes of action between XNC and XN treated MCF-7 cells could be postulated. XNC causes ER stress and seems to be involved in cell-cell adhesion, whereas XN influences cell cycles and DNA replication as well as type I interferon signaling pathway. The results demonstrate the utility of using quantitative proteomics for bioactivity screenings of minor hop compounds and underscore the importance of isolating highly pure compounds into their distinct forms to analyze their different and possibly synergistic activities and modes of action.

Citing Articles

Evaluation of In Vitro-Derived Hop Plantlets, cv. Columbus and Magnum, as Potential Source of Bioactive Compounds.

Leto L, Favari C, Agosti A, Del Vecchio L, Di Fazio A, Bresciani L Antioxidants (Basel). 2024; 13(8).

PMID: 39199155 PMC: 11351401. DOI: 10.3390/antiox13080909.

A proteomic landscape of pharmacologic perturbations for functional relevance.

Liu Z, Jiang S, Hao B, Xie S, Liu Y, Huang Y J Pharm Anal. 2024; 14(1):128-139.

PMID: 38352953 PMC: 10859532. DOI: 10.1016/j.jpha.2023.08.021.

A comprehensive review of the benefits of drinking craft beer: Role of phenolic content in health and possible potential of the alcoholic fraction.

Tirado-Kulieva V, Hernandez-Martinez E, Minchan-Velayarce H, Pasapera-Campos S, Luque-Vilca O Curr Res Food Sci. 2023; 6:100477.

PMID: 36935850 PMC: 10020662. DOI: 10.1016/j.crfs.2023.100477.

The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway.

Gupta K, Sharma K, Chandra H, Panwar H, Bhardwaj N, Altwaijry N Front Oncol. 2023; 12:950835.

PMID: 36591523 PMC: 9798915. DOI: 10.3389/fonc.2022.950835.

Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.

Alam M, Sultana A, Reza M, Amanullah M, Kabir S, Haque Mollah M PLoS One. 2022; 17(5):e0268967.

PMID: 35617355 PMC: 9135200. DOI: 10.1371/journal.pone.0268967.

References

Mendes V, Monteiro R, Pestana D, Teixeira D, Calhau C, Azevedo I . Xanthohumol influences preadipocyte differentiation: implication of antiproliferative and apoptotic effects. J Agric Food Chem. 2008; 56(24):11631-7. DOI: 10.1021/jf802233q. View

Shimo A, Tanikawa C, Nishidate T, Lin M, Matsuda K, Park J . Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci. 2007; 99(1):62-70. PMC: 11158784. DOI: 10.1111/j.1349-7006.2007.00635.x. View

Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z . GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009; 10:48. PMC: 2644678. DOI: 10.1186/1471-2105-10-48. View

Freeman A, Morris L, Mills A, Stoeber K, Laskey R, Williams G . Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res. 1999; 5(8):2121-32. View

Miranda C, Stevens J, Ivanov V, McCall M, Frei B, Deinzer M . Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem. 2000; 48(9):3876-84. DOI: 10.1021/jf0002995. View

Banerjee M, Singh P, Panda D . Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells. FEBS J. 2010; 277(16):3437-48. DOI: 10.1111/j.1742-4658.2010.07750.x. View

Nookandeh A, Frank N, Steiner F, Ellinger R, Schneider B, Gerhauser C . Xanthohumol metabolites in faeces of rats. Phytochemistry. 2004; 65(5):561-70. DOI: 10.1016/j.phytochem.2003.11.016. View

Shaikh N . Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol Rep. 1999; 6(6):1383-7. DOI: 10.3892/or.6.6.1383. View

Ong S, Mann M . Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol. 2006; 1(5):252-62. DOI: 10.1038/nchembio736. View

10.

Aebersold R, Mann M . Mass-spectrometric exploration of proteome structure and function. Nature. 2016; 537(7620):347-55. DOI: 10.1038/nature19949. View

11.

Johnson N, Shapiro G . Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors. Expert Opin Ther Targets. 2010; 14(11):1199-212. PMC: 3957489. DOI: 10.1517/14728222.2010.525221. View

12.

Nikolic D, van Breemen R . Analytical methods for quantitation of prenylated flavonoids from hops. Curr Anal Chem. 2013; 9(1):71-85. PMC: 3783999. View

13.

Zanoli P, Zavatti M . Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol. 2008; 116(3):383-96. DOI: 10.1016/j.jep.2008.01.011. View

14.

Legette L, Karnpracha C, Reed R, Choi J, Bobe G, Christensen J . Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Mol Nutr Food Res. 2013; 58(2):248-55. PMC: 4371792. DOI: 10.1002/mnfr.201300333. View

15.

Musgrove E, Sutherland R . Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer. 2009; 9(9):631-43. DOI: 10.1038/nrc2713. View

16.

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J . STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014; 43(Database issue):D447-52. PMC: 4383874. DOI: 10.1093/nar/gku1003. View

17.

Nuti E, Bassani B, Camodeca C, Rosalia L, Cantelmo A, Gallo C . Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues. Eur J Med Chem. 2017; 138:890-899. DOI: 10.1016/j.ejmech.2017.07.024. View

18.

Wu J, Liu T, Rios Z, Mei Q, Lin X, Cao S . Heat Shock Proteins and Cancer. Trends Pharmacol Sci. 2016; 38(3):226-256. DOI: 10.1016/j.tips.2016.11.009. View

19.

Stompor M, Zarowska B . Antimicrobial Activity of Xanthohumol and Its Selected Structural Analogues. Molecules. 2016; 21(5). PMC: 6272900. DOI: 10.3390/molecules21050608. View

20.

Karabin M, Hudcova T, Jelinek L, Dostalek P . Biologically Active Compounds from Hops and Prospects for Their Use. Compr Rev Food Sci Food Saf. 2021; 15(3):542-567. DOI: 10.1111/1541-4337.12201. View